Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02702440
What this trial is testing

Meta-analyses of Liquid Versus Solid Calories and Body Weight

Who this might be right for
Diabetes MellitusChronic DiseaseCardiovascular Diseases+4 more
John Sievenpiper 1
Not applicableStudy completedNCT02234908
What this trial is testing

Rewards for Tuberculosis Contact Screening

Who this might be right for
TuberculosisDrug-resistant Tuberculosis
Boston University 301
Not applicableStudy completedNCT02007343
What this trial is testing

Burden of Antibiotic Resistance in Gram-Negative Infections in Dutch Hospitals

Who this might be right for
Infection Resistant to DrugsGram-Negative Bacterial Infection
UMC Utrecht 3,895
Not applicableStudy completedNCT00881985
What this trial is testing

Effect of Continuous Positive Airway Pressure for Treatment of Obstructive Sleep Apnea on Resistant Hypertension

Who this might be right for
Resistant HypertensionObstructive Sleep Apnea
The University of Hong Kong 92
Not applicableEnded earlyNCT07014735
What this trial is testing

Effect of Hyperglycaemia and Moxifloxacin on QTc Interval in T2DM

Who this might be right for
Diabetes Type 2Hyperglycaemia (Diabetic)QT Interval, Variation in+1 more
Richmond Pharmacology Limited 14
Not applicableUnknownNCT04634695
What this trial is testing

Assessing to What Extent Dhps-431V Mutation May Influence the Protective Efficacy of IPTp-SP

Who this might be right for
Pregnancy Malaria
Obafemi Awolowo University 288
Post-approval studies (Phase 4)Study completedNCT00001967
What this trial is testing

Intermittent Versus Continuous Medication in the Treatment of HIV

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 123
Not applicableStudy completedNCT05599633
What this trial is testing

Effect of Sago-based Product on Glycaemic and Lipid Control in Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Sarawak General Hospital 82
Large-scale testing (Phase 3)Study completedNCT01963208
What this trial is testing

Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

Who this might be right for
Drug Resistant Partial Onset Seizure
Marinus Pharmaceuticals 405
Not applicableStudy completedNCT02824640
What this trial is testing

Patient-Centered Models of HCV Care for People Who Inject Drugs

Who this might be right for
Hepatitis CMedication Adherence
Prisma Health-Upstate 755
Post-approval studies (Phase 4)Study completedNCT02485691
What this trial is testing

Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent

Who this might be right for
Prostate Cancer Metastatic
Sanofi 255
Not applicableLooking for participantsNCT06232213
What this trial is testing

Clinical Study of Individualized Treatment of Relapsed or Drug-resistant Advanced Gynecological Tumors Guided by PTC Model

Who this might be right for
Personalized Cancer Treatment
Hua Li 40
Testing effectiveness (Phase 2)Study completedNCT02903160
What this trial is testing

Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer
Icahn School of Medicine at Mount Sinai 40
Testing effectiveness (Phase 2)Study completedNCT00029341
What this trial is testing

Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Testing effectiveness (Phase 2)Study completedNCT04979910
What this trial is testing

Targeting IL-17A for Treatment-Resistant Depression

Who this might be right for
Major Depressive Disorder
Icahn School of Medicine at Mount Sinai 7
Not applicableStudy completedNCT05549427
What this trial is testing

Ventilator Associated Pneumonia by Multi-Drug Resistant Organism

Who this might be right for
Ventilator Associated PneumoniaMulti-antibiotic Resistance
Sultan Qaboos University 319
Post-approval studies (Phase 4)UnknownNCT01594905
What this trial is testing

Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection

Who this might be right for
Chronic Hepatitis B
Yonsei University 90
Post-approval studies (Phase 4)UnknownNCT02162966
What this trial is testing

Safety and Efficacy Study of High Dose Colistin

Who this might be right for
Infectious Diseases
King Saud Medical City 330
Not applicableEnrolling By InvitationNCT03702127
What this trial is testing

TMS - Intracranial Electrodes

Who this might be right for
Epilepsy Intractable
Aaron Boes 50
Large-scale testing (Phase 3)Study completedNCT02707861
What this trial is testing

Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1

Who this might be right for
HIV
TaiMed Biologics Inc. 79
Next Page